author-photo

Basel Rouphail

Cleveland Clinic

11

Papers

21

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

A Phase 2 Trial of Imatinib Mesylate as Maintenance Therapy for Patients with Newly Diagnosed C-kit Positive Acute Myeloid Leukemia

2020 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (2)
Grade 3 Follicular Lymphoma: Outcomes in the Rituximab Era

2017 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (10)
Is rituximab sub-optimally dosed in indolent B cell lymphoma?

2016 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (4)
The Role of Post- Treatment Imaging in Detection of Relapsed Disease in Classical Hodgkin Lymphoma: The Cleveland Clinic Experience

2015 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Is rituximab sub-optimally dosed in indolent B cell lymphoma?

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Grade 3 Follicular Lymphoma: Outcomes in the Rituximab Era

2015 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Efficacy of Standard Dose R-CHOP Alternating with R-HiDAC Followed By ASCT As Initial Therapy of Mantle Cell Lymphoma: Cleveland Clinic Experience

2014 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Clinical experiences with ruxolitinib in symptomatic patients with myeloproliferative neoplasm with chronic kidney disease

2014 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (4)
Molecular Diversity Detected by Whole Exome Sequencing in Chronic Myelomonocytic Leukemia

2012 Blood
Show All
- Source
- Cite
- Save
Citations (0)
A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed C-Kit Positive Acute Myeloid Leukemia (AML)

2012 Blood
Show All
- Source
- Cite
- Save
Citations (0)